206 related articles for article (PubMed ID: 20486460)
1. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Lonergan CL; McNamara EK; Cordoro KM; Greer KE
Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
4. Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.
Boonchai W
Arch Dermatol; 2006 Apr; 142(4):531-2. PubMed ID: 16618886
[No Abstract] [Full Text] [Related]
5. [Arsenical keratoses and carcinomas].
Fumal I; Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2005 Apr; 60(4):217-21. PubMed ID: 15943097
[TBL] [Abstract][Full Text] [Related]
6. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Oster-Schmidt C; Altmeyer P; Markus S
J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
[TBL] [Abstract][Full Text] [Related]
7. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Quirk C; Gebauer K; Owens M; Stampone P
Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod to treat intraepidermal carcinoma.
Hengge UR; Stark R
Arch Dermatol; 2001 Jun; 137(6):709-11. PubMed ID: 11405756
[No Abstract] [Full Text] [Related]
9. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
Warshauer E; Warshauer BL
J Drugs Dermatol; 2008 May; 7(5):447-51. PubMed ID: 18505136
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
12. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
Oster-Schmidt C
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
[TBL] [Abstract][Full Text] [Related]
13. Update on actinic keratosis in clinical trial experience with imiquimod.
Ferrándiz C
Br J Dermatol; 2007 Dec; 157 Suppl 2():32-3. PubMed ID: 18067629
[TBL] [Abstract][Full Text] [Related]
14. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
[No Abstract] [Full Text] [Related]
16. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
Dirschka T; Schmitz L; Bartha Á
Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
[No Abstract] [Full Text] [Related]
17. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
18. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
19. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
20. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
Quirk C; Gebauer K; De'Ambrosis B; Slade HB; Meng TC
Cutis; 2010 Jun; 85(6):318-24. PubMed ID: 20666194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]